Skip to main content
SELLAS Life Sciences Group, Inc. (SLS)
NASDAQ: SLS · Real-Time Price · USD
7.86
-0.17 (-2.12%)
At close: Nov 13, 2026, 4:00 PM EST
7.81
-0.05 (-0.68%)
After-hours: Nov 13, 2026, 7:59 PM EST

SLS Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
----17.6
Revenue Growth
-----86.84%300.00%
Gross Profit
----0.97.4
Operating Income
-37.35-27.17-31.51-37.87-31.95-19.59
Net Income
-35.76-26.86-30.88-37.34-41.3-20.7
Earnings Per Share
-0.20-0.25-0.50-1.34-2.13-1.34
EPS Growth
------

Cash & Debt
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
134.7171.7913.892.5317.1321.36
Total Debt
0.6110.910.950.81
Net Cash (Debt)
134.1170.7912.891.6216.1820.55
Net Cash Growth
206.75%449.41%693.41%-89.96%-21.25%-40.12%
Net Cash Per Share
0.760.650.210.060.831.33

Cash Flow & CapEx
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-27.3-28.39-35.4-31.41-23.81-26.02
Capital Expenditures
------
Free Cash Flow
-27.3-28.39-35.4-31.41-23.81-26.02
Free Cash Flow Growth
------

Margins
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
----90.00%97.37%
Operating Margin
-----3195.00%-257.82%
Pretax Margin
-----4130.10%-275.47%
Profit Margin
-----4130.10%-272.36%
FCF Margin
-----2380.90%-342.38%

Valuation
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
----48.5911.56